News Headlines Article

Senators want to halt change to Medicare Part B drug pay
Modern Healthcare

Senate Finance Committee members from both parties told the CMS on Thursday not to go forward with a Medicare Part B initiative to change how hospitals and doctors are reimbursed for outpatient drugs.

The CMS announced the mandatory change last month to criticism from some doctors and insurers as well as the pharmaceutical lobby. The five-year pilot program borne out of the Center for Medicare and Medicaid Innovation would, starting this year, decrease the percentage of a drug’s average sales price paid to providers from 6% to 2.5% while adding a flat payment of $16.80 per drug a day.